Investors bought shares of UnitedHealth Group Inc (NYSE:UNH) on weakness during trading hours on Friday. $397.58 million flowed into the stock on the tick-up and $280.08 million flowed out of the stock on the tick-down, for a money net flow of $117.50 million into the stock. Of all companies tracked, UnitedHealth Group had the 9th highest net in-flow for the day. UnitedHealth Group traded down ($6.06) for the day and closed at $258.18
UNH has been the topic of a number of recent research reports. Leerink Swann reaffirmed an “outperform” rating on shares of UnitedHealth Group in a report on Wednesday, July 18th. Raymond James increased their target price on UnitedHealth Group from $285.00 to $304.00 and gave the stock a “strong-buy” rating in a report on Monday, September 24th. ValuEngine downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Tuesday, September 11th. Zacks Investment Research upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $287.00 price objective for the company in a research note on Sunday, July 15th. Finally, Citigroup increased their price objective on shares of UnitedHealth Group from $275.00 to $288.00 and gave the stock a “$255.42” rating in a research note on Wednesday, July 18th. One analyst has rated the stock with a hold rating, twenty-two have given a buy rating and one has issued a strong buy rating to the company’s stock. UnitedHealth Group has an average rating of “Buy” and a consensus price target of $289.41.
The company has a market capitalization of $248.49 billion, a P/E ratio of 21.20, a P/E/G ratio of 1.49 and a beta of 0.73. The company has a debt-to-equity ratio of 0.61, a quick ratio of 0.75 and a current ratio of 0.69.
In other news, CEO Steven H. Nelson sold 8,142 shares of the firm’s stock in a transaction that occurred on Thursday, September 13th. The shares were sold at an average price of $265.00, for a total transaction of $2,157,630.00. Following the sale, the chief executive officer now owns 22,496 shares of the company’s stock, valued at approximately $5,961,440. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Richard T. Burke sold 20,000 shares of the stock in a transaction that occurred on Wednesday, September 12th. The shares were sold at an average price of $263.41, for a total value of $5,268,200.00. Following the transaction, the director now owns 1,720,112 shares in the company, valued at approximately $453,094,701.92. The disclosure for this sale can be found here. Insiders have sold a total of 94,568 shares of company stock worth $24,950,027 in the last ninety days. Corporate insiders own 0.87% of the company’s stock.
Several large investors have recently made changes to their positions in the company. FMR LLC lifted its position in shares of UnitedHealth Group by 5.1% during the 2nd quarter. FMR LLC now owns 61,622,355 shares of the healthcare conglomerate’s stock valued at $15,118,428,000 after buying an additional 2,981,233 shares in the last quarter. Wells Fargo & Company MN lifted its holdings in UnitedHealth Group by 0.5% in the 2nd quarter. Wells Fargo & Company MN now owns 7,692,899 shares of the healthcare conglomerate’s stock valued at $1,887,377,000 after purchasing an additional 39,480 shares in the last quarter. Jennison Associates LLC lifted its holdings in UnitedHealth Group by 12.0% in the 2nd quarter. Jennison Associates LLC now owns 6,616,652 shares of the healthcare conglomerate’s stock valued at $1,623,329,000 after purchasing an additional 710,745 shares in the last quarter. Summit Trail Advisors LLC lifted its holdings in UnitedHealth Group by 19,286.4% in the 1st quarter. Summit Trail Advisors LLC now owns 6,228,065 shares of the healthcare conglomerate’s stock valued at $6,228,000 after purchasing an additional 6,195,939 shares in the last quarter. Finally, Morgan Stanley lifted its holdings in UnitedHealth Group by 5.2% in the 2nd quarter. Morgan Stanley now owns 5,498,557 shares of the healthcare conglomerate’s stock valued at $1,349,017,000 after purchasing an additional 269,652 shares in the last quarter. Hedge funds and other institutional investors own 85.45% of the company’s stock.
UnitedHealth Group Company Profile (NYSE:UNH)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Recommended Story: What are earnings reports?
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.